AbbVie (ABBV)
Develops immunology, neuroscience, oncology, and aesthetics products led by Skyrizi and Rinvoq.
$265.35
vs last close+0.87 (+0.33%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 76.22% | 1.35B shares | |
|---|---|---|---|
| 4,342 holders · as of Jun 30, 2026 | |||
| Insiders | 0.08% | 1.48M shares | |
| 25 holders · as of Aug 18, 2026 | |||
| Strategic holders | 7.26% | 128.20M shares | |
| 2 holders · as of Jul 11, 2025 | |||
| Other | 16.44% | 290.55M shares | |
| remainder | |||
1.77B company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
4,342 holders · 1.35B shares · 295 new positions · 2,214 increased · 1,554 reduced · 173 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 149.49M | 8.46% | −1.21M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 115.40M | 6.53% | +515.8K | Aug 13, 2026 |
| State Street Corp | 82.60M | 4.67% | +1.38M | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 48.48M | 2.74% | −1.05M | Aug 13, 2026 |
| JPMorgan Chase & Co | 47.86M | 2.71% | −8.88M | Aug 12, 2026 |
| Geode Capital Management, LLC | 47.00M | 2.66% | +260.9K | Aug 12, 2026 |
| Morgan Stanley | 38.90M | 2.20% | +884.2K | Aug 13, 2026 |
| Capital Research Global Investors | 30.10M | 1.70% | −1.15M | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 7.51% | 132.92M | 13G | Apr 29, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 14, 2026 | Nicholas Donoghoeofficer: EVP, CHIEF BUS/STRAT OFFICER | Sale | 32,710 | $250.00 | 74,430 |
| Mar 4, 2026 | David Ryan Purdueofficer: SVP, Controller | Sale | 5,230 | $233.56 | 2,654 |
| Mar 2, 2026 | Perry C. Siatisofficer: EVP, GC AND SECRETARY | Sale · 3 lots | 18,668 | $234.39 | 4,619 |
| Feb 25, 2026 | Perry C. Siatisofficer: EVP, GC AND SECRETARY | Sale | 22,381 | $230.00 | 38,137 |
House and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Pete Sessions · TX17 | Sale | $15,001 – $50,000 | Sep 14, 2026 | Sep 21, 2026 | |
| Rep. Ro Khanna · CA17 | Purchase | $15,001 – $50,000 | May 1, 2026 | Jun 11, 2026 | |
| Rep. Josh Gottheimer · NJ05 | Sale | $1,001 – $15,000 | Joint | May 5, 2026 | Jun 4, 2026 |